Identifying celiac disease: Cutaneous, neurological, and other symptoms – what diagnostic tests confirm gluten-sensitive enteropathy?

Symptoms of celiac disease often develop gradually and exhibit a broad clinical spectrum. Initially, patients frequently report non-specific gastrointestinal complaints such as recurrent abdominal distension, excessive flatulence, borborygmus, and mild cramping. As mucosal damage progresses and small intestinal villi undergo atrophy, malabsorption syndromes become clinically prominent.

These include chronic diarrhea—often characterized by pale, bulky, and foul-smelling fatty stools (steatorrhea)—alongside unexplained weight loss and nutritional deficiencies leading to iron-deficiency anemia or megaloblastic anemia. Furthermore, adult patients may present with extraintestinal and secondary complications such as reduced bone mineral density (osteopenia and osteoporosis), menstrual irregularities, infertility, chronic fatigue, and depressive symptoms that significantly impair quality of life.

Among the extraintestinal manifestations of celiac disease, dermatitis herpetiformis (also known as Duhring's disease) represents the specific cutaneous counterpart of gluten-sensitive enteropathy. This chronic autoimmune blistering skin condition is directly triggered by dietary gluten ingestion, even in patients who exhibit minimal or absent gastrointestinal symptoms.

Clinically, dermatitis herpetiformis presents with intensely pruritic, polymorphic skin lesions, including erythematous plaques, papules, and clusters of tense vesicles. Due to severe pruritus, scratching frequently results in excoriations, secondary bacterial infections, and occasional scarring. These characteristic lesions typically manifest symmetrically on extensor surfaces such as the elbows and knees, as well as the buttocks, sacral region, and scalp or face.

Neurological and psychiatric complications are increasingly recognized in the comprehensive assessment of celiac disease. Clinical research indicates that systemic autoimmune mechanisms and chronic malabsorption triggered by gluten can affect both the central and peripheral nervous systems. Peripheral neuropathy, characterized by symmetrical distal paresthesias, numbness, and burning sensations, is among the most frequent neurological findings.

Other documented manifestations include gluten ataxia (inordinateness of gait and limb movements), treatment-resistant epilepsy, severe migraines, cognitive deficits (“brain fog”), anxiety, and depression. Prompt implementation of a strict gluten-free diet often halts progression and can significantly ameliorate these neurological symptoms.

Diagnosing celiac disease requires a comprehensive, multi-step approach combining blood serology, upper gastrointestinal endoscopy with mucosal biopsy, and genetic testing. Initial evaluation typically involves screening for specific autoantibodies, notably tissue transglutaminase IgA (tTG-IgA) and endomysial antibodies (EMA-IgA), alongside total serum IgA to rule out selective IgA deficiency.

The established gold standard for confirming celiac disease in adults remains an upper endoscopy featuring multiple duodenal biopsies, allowing pathologists to evaluate villous architecture according to the Marsh classification. Furthermore, genetic testing for human leukocyte antigen (HLA) DQ2 and DQ8 haplotypes provides an exceptionally high negative predictive value; the absence of these genes effectively rules out celiac disease, guiding clinical management efficiently.